The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta-analysis.

Cohen, Hagar; Mahajna, Ghadeer; Ben-Shushan, Tomer; Matok, Ilan; Eyal, Sara

Cohen, Hagar; Mahajna, Ghadeer; Ben-Shushan, Tomer; Matok, Ilan; Eyal, Sara.

Afiliação

Cohen H; Department of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.
Mahajna G; Department of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.
Ben-Shushan T; Medical Library Authority, Hebrew University of Jerusalem, Jerusalem, Israel.
Matok I; Department of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.
Eyal S; Department of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.

Epilepsia ; 65(2): 445-455, 2024 Feb.

Article em En | MEDLINE | ID: mdl-38010146

Assuntos

Carbamatos; Clorofenóis; Citocromo P-450 CYP3A; Fenitoína; Tetrazóis; Humanos; Fenitoína/uso terapêutico; Metanálise em Rede; Preparações Farmacêuticas/metabolismo; Carbamazepina/uso terapêutico; Benzodiazepinas

Palavras-chave

AUC; CYP3A4; antiepileptic drugs; drug interactions; systematic review and meta-analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenitoína / Tetrazóis / Carbamatos / Clorofenóis / Citocromo P-450 CYP3A Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google